Intravascular hemolysis in patients with prosthetic valves and valvular heart disease.
D000747:Anemia, Hypochromic / Q000188:drug therapy; D001792:Blood Platelets / Q000502:physiology; D002859:Chromium Isotopes; D004697:Endocarditis, Bacterial / Q000097:blood; D004912:Erythrocytes / Q000032:analysis; D004920:Erythropoiesis; D005492:Folic Acid / Q000097:blood; D006242:Haptoglobins / Q000032:analysis; D006349:Heart Valve Diseases / Q000150:complications*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006418:Heme / Q000032:analysis; D006461:Hemolysis; D006801:Humans; D007501:Iron / Q000652:urine; D007770:L-Lactate Dehydrogenase / Q000097:blood; D010406:Penicillins / Q000627:therapeutic use; D005082:Physical Exertion; D012709:Serum Albumin; D013997:Time Factors
D002859:Chromium Isotopes; D006242:Haptoglobins; D010406:Penicillins; D012709:Serum Albumin; D006418:Heme; D005492:Folic Acid; D007501:Iron; D007770:L-Lactate Dehydrogenase